Yue Zhang

Elevated PD-L1 expression predicts poor survival outcomes in patients with cervical cancer

Xiaobin Gu, Meilian Dong, Zheyan Liu et al. · Cancer Cell International · 2019 · 62 citations · Full text

Gemcitabine plus nab-paclitaxel for advanced pancreatic cancer after first-line FOLFIRINOX: single institution retrospective review of efficacy and toxicity

Yue Zhang, Howard S. Höchster, Stacey Stein et al. · Experimental Hematology and Oncology · 2015 · 60 citations · Full text

First-Line Treatments for Extensive-Stage Small-Cell Lung Cancer With Immune Checkpoint Inhibitors Plus Chemotherapy: A Network Meta-Analysis and Cost-Effectiveness Analysis

Shuo Kang, Xinchen Wang, Yue Zhang et al. · Frontiers in Oncology · 2022 · 46 citations · Full text

A pooled analysis of the prognostic value of PD-L1 in melanoma: evidence from 1062 patients

Jing Yang, Meilian Dong, Yifang Shui et al. · Cancer Cell International · 2020 · 37 citations · Full text

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases

J. Randolph Hecht, Steven S. Raman, Arlene Chan et al. · ESMO Open · 2023 · 32 citations · Full text